We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
501
Marsh
MRSH
$91.4B
$1.85M 0.02%
27,564
+1,067
+4% +$71.5K
BAX icon
502
Baxter International
BAX
$14.1B
$1.85M 0.02%
38,846
+9,150
+31% +$431K
LH icon
503
Labcorp
LH
$25.4B
$1.85M 0.02%
15,644
+1,081
+7% +$127K
BETR
504
DELISTED
Amplify Snack Brands, Inc.
BETR
$1.84M 0.02%
113,820
+54,500
+92% +$853K
GDX icon
505
VanEck Gold Miners ETF
GDX
$25.5B
$1.84M 0.02%
69,632
+5,500
+9% +$158K
BX icon
506
Blackstone
BX
$109B
$1.84M 0.02%
71,913
-9,622
-12% -$254K
YHOO
507
DELISTED
Yahoo Inc
YHOO
$1.83M 0.02%
42,502
-1,702
-4% -$69.8K
BDSI
508
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.81M 0.02%
670,797
+215,079
+47% +$546K
IPHI
509
DELISTED
INPHI CORPORATION
IPHI
$1.81M 0.02%
41,510
-2,290
-5% -$88.4K
IGIB icon
510
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.8M 0.02%
32,318
-11,156
-26% -$621K
GD icon
511
General Dynamics
GD
$104B
$1.8M 0.02%
11,589
+109
+0.9% +$16.2K
RAMP icon
512
LiveRamp
RAMP
$2.3B
$1.8M 0.02%
67,430
+4,650
+7% +$115K
NUV icon
513
Nuveen Municipal Value Fund
NUV
$1.9B
$1.78M 0.02%
+167,852
New +$1.79M
PFNX
514
DELISTED
Pfenex Inc.
PFNX
$1.78M 0.02%
198,475
+40,624
+26% +$347K
IWB icon
515
iShares Russell 1000 ETF
IWB
$49.8B
$1.76M 0.02%
14,637
+588
+4% +$70.7K
ATRC icon
516
AtriCure
ATRC
$2B
$1.75M 0.02%
110,770
+10,585
+11% +$163K
BR icon
517
Broadridge
BR
$18.9B
$1.75M 0.02%
25,760
-9
-0% -$614
CRTO icon
518
Criteo S.A. Ordinary Shares
CRTO
$857M
$1.73M 0.02%
49,355
-630
-1% -$24.9K
CIVB icon
519
Civista Bancshares
CIVB
$600M
$1.71M 0.02%
120,523
SBH icon
520
Sally Beauty Holdings
SBH
$1.51B
$1.71M 0.02%
66,475
-759,684
-92% -$21.3M
GKOS icon
521
Glaukos
GKOS
$10.1B
$1.69M 0.02%
44,821
+14,563
+48% +$482K
AMLP icon
522
Alerian MLP ETF
AMLP
$12.8B
$1.68M 0.01%
26,420
+6,209
+31% +$393K
AFSI
523
DELISTED
AmTrust Financial Services, Inc.
AFSI
$1.67M 0.01%
62,274
-14,391
-19% -$369K
WNS
524
DELISTED
WNS Holdings
WNS
$1.67M 0.01%
55,589
-10,701
-16% -$308K
CMG icon
525
CALL
Chipotle Mexican Grill
CMG
$43.7B
$1.65M 0.01%
+195,000
New +$1.6M

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.